@article{b67755b7c15d46b79ca8bbfe749c89fb,
title = "Cholesterol insights and controversies from the UK biobank study three take-home messages for the busy clinician",
keywords = "Apolipoproteins B, Cholesterol, LDL, Editorials, Lipids, Risk",
author = "Samia Mora and Martin, {Seth S.} and Virani, {Salim S.}",
note = "Funding Information: Dr Mora has received support from the National Institutes of Health (HL134811, HL117861, HL136852, DK112940). Dr Martin has received research support from the PJ Schafer Cardiovascular Research Fund, David and June Trone Family Foundation, American Heart Association, Aetna Foundation, National Institutes of Health, CASCADE FH (Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia), Akcea, Maryland Innovation Initiative, iHealth, Stanford MedX, Nokia, Google, and Apple. Dr Virani receives research support from the Department of Veterans Affairs Health Services Research & Development (IIR 16-072), World Heart Federation, and the Jooma and Tahir family. This work was also supported by the Houston VA Health Services Research & Development Center for Innovations grant (HFP 90-020). Funding Information: Dr Mora has received research support from Atherotech Diagnostics and the National Heart, Lung, and Blood Institute and has served as a consultant to Quest Diagnostics and Pfizer. Dr Martin is a coinventor of a system to estimate LDL cholesterol levels, patent application pending; he has served as a consultant to Sanofi, Regeneron, Amgen, Quest Diagnostics, Akcea, Novo Nordisk, and Esperion. Dr Virani receives honorarium from the American College of Cardiology in his role as the associate editor for innovations (acc.org).",
year = "2019",
month = aug,
day = "13",
doi = "10.1161/CIRCULATIONAHA.119.042134",
language = "English",
volume = "140",
pages = "553--555",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "7",
}